Key Takeaways & Executive Findings
- •• A commercial cell separation system (C-SVF) yields viable SVF cells comparable to laboratory enzymatic digestion, with enhanced proliferation and reduced apoptosis in vitro. • In a mouse wound model, C-SVF significantly accelerates wound closure, improves collagen remodeling, and promotes angiogenesis. • Single-nucleus RNA sequencing reveals that C-SVF is enriched with APOE+ adipose-derived stem cells and M2 anti-inflammatory macrophages, which jointly drive wound repair. • The commercial extraction system offers an effective, clinically viable method for isolating therapeutic SVF cells, potentially improving regenerative therapy outcomes.
Abstract
Background In the field of regenerative therapy, the stromal vascular fraction (SVF) extracted from adipose tissue has been widely recognized for its significant benefits. However, the cellular composition and therapeutic effect of SVF products prepared via different methods are unclear. Methods SVF cells were obtained via three approaches: (1) generation of the SVF via mechanical emulsification (M-SVF), (2) generation of the SVF via laboratory enzymatic digestion (L-SVF), and (3) generation of the SVF via commercial cell separation systems (C-SVF). We evaluated their healing effects on mouse wounds. Additionally, we utilized single-nucleus RNA sequencing (snRNA-seq) technology to explore the cellular composition of the C-SVF. Results The cell yield of C-SVF was comparable to that of L-SVF. During in vitro culture, C-SVF exhibited enhanced proliferation and a reduced proportion of apoptotic cells. In a mouse wound model, the application of C-SVF facilitated the closure of mouse wounds and improved collagen remodeling and angiogenesis in the wound area. Additional snRNA-seq analysis revealed that APOE+ adipose-derived stem cells and immune cells, especially M2 anti-inflammatory macrophages, are enriched in C-SVF, which together promote wound repair, and that APOE+ adipose-derived stem cells (ADSCs) and immune cells, especially M2 anti-inflammatory macrophages, are enriched in C-SVF, which jointly regulate and promote wound repair. Conclusion A commercial extraction system is an effective method for isolating viable SVF cells enriched with APOE+ ADSCs and M2 macrophages.
1. Introduction
Stem cell therapy has recently gained widespread acceptance in regenerative medicine, covering a range of treatments for conditions such as stubborn wounds, ischemic conditions, and tissue deficiencies. Adipose-derived stem cells (ADSCs) have increased in prominence as preferred stem cells because of their facile procurement, high storage capacity, and rapid proliferation kinetics [1]. The stromal vascular fraction (SVF), a recently emerged derivative of adipose tissue, has sparked widespread research endeavors. Its abundant bioactive substances, including notably ADSCs and matrix components, have positioned it as a viable solution for treating stubborn wounds [2–4].
At present, there is no broad consensus on the standard separation procedure for SVFs. Typically, separation methods can be classified into two main categories on the basis of whether collagenase is used to assist in the breakdown of the extracellular matrix (ECM) of adipocytes: enzymatic methods and nonenzymatic methods. Nonenzymatic (mechanical) methods rely mainly on physical operations such as emulsification, centrifugation, oscillation, and vortexing to disrupt the ECM and concentrate cellular components [5, 6]. The enzymatic method results in a high yield of SVF cells but is more expensive, has a longer preparation time, and has a greater risk of contamination. In contrast, nonenzymatic methods are less labor intensive, time saving, and easier to use in clinical practice; however, it is still uncertain whether they have regenerative effects comparable to those of enzymatic methods [7].
To obtain SVFs more conveniently and quickly during surgery, a range of semi or fully automatic separation and extraction devices have been introduced to the market [8]. Among these devices, Celution 800 was proven to be more effective with rapid processing time, greater viable cell yield, a lower residual enzyme level and a reduced cost [9]. Celution 800 has been widely used in different indications and has achieved significant results [10–12].
Loading authentic research manuscript (Pages 1–5)...
Shunxin Han, Qian Zhang, Feng Lu, Junrong Cai (2026). Therapeatic evaluation and single cell analysis of adipose stromal vascular fraction isolation from a commercial cell separation system. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-025-04732-5
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the stromal vascular fraction (SVF) and why is it important?
The stromal vascular fraction (SVF) is a heterogeneous mixture of cells derived from adipose tissue, including adipose-derived stem cells (ADSCs), immune cells, and endothelial cells. It is important in regenerative medicine because it contains bioactive substances that promote tissue repair and has been used to treat chronic wounds and other conditions.
How does the commercial cell separation system (C-SVF) compare to other SVF isolation methods?
The study found that C-SVF yields a comparable number of viable cells to laboratory enzymatic digestion (L-SVF), but with enhanced proliferation and reduced apoptosis in vitro. In a mouse wound model, C-SVF accelerated wound closure and improved collagen remodeling and angiogenesis, indicating its effectiveness as an isolation method.
What are the key cellular components enriched in C-SVF that contribute to wound healing?
Single-nucleus RNA sequencing revealed that C-SVF is enriched with APOE+ adipose-derived stem cells (ADSCs) and M2 anti-inflammatory macrophages. These cell types work together to promote wound repair by regulating inflammation and supporting tissue regeneration.
What are the advantages of using a commercial cell separation system over traditional methods?
Commercial systems like Celution 800 offer rapid processing time, greater viable cell yield, lower residual enzyme levels, and reduced cost compared to manual enzymatic methods. They are also more convenient and easier to use in clinical settings, making them a practical choice for point-of-care SVF isolation.
What is the significance of using single-nucleus RNA sequencing in this study?
Single-nucleus RNA sequencing (snRNA-seq) provides a detailed cellular composition analysis of the SVF, allowing researchers to identify specific cell populations, such as APOE+ ADSCs and M2 macrophages, that are enriched in C-SVF. This helps elucidate the mechanisms underlying the therapeutic effects of SVF and guides optimization of isolation protocols.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.